Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | IAPP | P10997 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6805430 | 0.93 | L3MBTL1 (0.57) | L3MBTL1GABRA1GABRB2AKR1B1CYP3A4 | |
| Benzene SCHEMBL10992898 | 0.90 | L3MBTL1 (0.60) | L3MBTL1AKR1B1CYP3A4ALDH1A1LMNA | |
| SCHEMBL26564933 | 0.85 | L3MBTL1 (0.47) | L3MBTL1GABRA1GABRB2AKR1B1CYP3A4 | |
| SCHEMBL80263 | 0.84 | L3MBTL1 (0.50) | L3MBTL1AKR1B1CYP3A4ALDH1A1LMNA | |
| SCHEMBL3687049 | 0.84 | AKR1B1 (0.61) | L3MBTL1AKR1B1ALDH1A1LMNAGAA | |
| SCHEMBL29676820 | 0.84 | AKR1B1 (0.61) | L3MBTL1AKR1B1ALDH1A1LMNAGAA | |
| SCHEMBL20185977 | 0.84 | PTGS2 (0.42) | L3MBTL1GABRA1GABRB2ALDH1A1SHBG | |
| SCHEMBL4960853 | 0.83 | GABRA1 (0.48) | L3MBTL1GABRA1GABRB2AKR1B1ALDH1A1 | |
| SCHEMBL4935061 | 0.83 | GABRA1 (0.48) | GABRA1GABRB2AKR1B1ALDH1A1SHBG | |
| Acetic Acid SCHEMBL1724578 | 0.82 | GABRA1 (0.52) | L3MBTL1GABRA1GABRB2AKR1B1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117250289-A | Method for detecting content of p-methyl propiophenone in sample | 湖南新领航检测技术有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-108997957-A | A kind of white EVA packaging adhesive film and preparation method thereof | 江苏鹿山光电科技有限公司 | 2018-12-14 | — | — | CN | claimed |
| CN-105542702-B | A kind of ultraviolet curing urethane adhesive and preparation method thereof | 华南理工大学 | 2018-11-13 | — | — | CN | claimed |
| CN-105542702-A | Ultraviolet-cured polyurethane adhesive and preparation method thereof | UNIV SOUTH CHINA TECH | 2016-05-04 | — | — | CN | claimed |
| CN-119330913-A | Preparation method of eperisone hydrochloride | 康普药业股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| US-20230348529-A1 | CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES | FORSCHUNGSVERBUND BERLIN EV (DE) | 2023-11-02 | — | — | US | disclosed |
| US-11746124-B2 | Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2023-09-05 | — | — | US | disclosed |
| US-20230250086-A1 | METHIONINE METABOLIC PATHWAY INHIBITORS | MIGAL - GALILEE RESEARCH INSTITUTE LTD. (IL) | 2023-08-10 | — | — | US | disclosed |
| US-11639345-B2 | Methionine metabolic pathway inhibitors | MIGAL—GALILEE RESEARCH INSTITUTE LTD. (IL) | 2023-05-02 | — | — | US | disclosed |
| WO-2019078246-A1 | IDO/TDO INHIBITOR | 一般社団法人ファルマバレープロジェクト支援機構 | 2019-04-25 | — | — | WO | disclosed |
| CN-108997957-A | A kind of white EVA packaging adhesive film and preparation method thereof | 江苏鹿山光电科技有限公司 | 2018-12-14 | — | — | CN | disclosed |
| EP-1688418-B1 | Chemokine receptor antagonists and methods of use thereof | MILLENNIUM PHARM INC (US) | 2017-03-15 | — | — | EP | disclosed |
| EP-0654534-B1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEM (JP) | 2000-03-01 | — | — | EP | disclosed |
| EP-0939134-A1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-01 | — | — | EP | disclosed |
| EP-0924193-A1 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
| EP-0924194-A2 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
| US-5811293-A | CULTURE PRODUCT AS CHEMICAL INTERMEDIATE FOR ANTI-OBESITY AGENT | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-09-22 | — | — | US | disclosed |
| US-5629200-A | MICROORGANISM | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0654534-A2 | Processes for producing optically active 2-amino-1-phenylethanol derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-24 | — | — | EP | disclosed |
| EP-0200942-A2 | New derivatives of an aminoketone | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1986-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639345-B2 | Methionine metabolic pathway inhibitors | GSS, MTR, CTH | L3MBTL1 1535/4885GABRA1 2805/4885GABRB2 1839/4885 |
| US-20230250086-A1 | METHIONINE METABOLIC PATHWAY INHIBITORS | GSS, MTR, CTH | L3MBTL1 1535/4885GABRA1 2805/4885GABRB2 1839/4885 |
| US-20230348529-A1 | CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES | PFAS, PHOSPHO1, PNKP | L3MBTL1 4493/4885GABRA1 3909/4885GABRB2 4258/4885 |
| US-11746124-B2 | Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates | PFAS, PHOSPHO1, PNKP | L3MBTL1 4493/4885GABRA1 3909/4885GABRB2 4258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.